Search research articles
Contact Us
Filters
Showing results (171-180 of 185) with videos related to
Page
of 19
Sort By:
Journal of Cardiac Failure
|
December 22, 2015
Response to Exercise Training and Outcomes in Patients With Heart Failure and Diabetes Mellitus: Insights From the HF-ACTION Trial
Adam Z Banks, Robert J Mentz, Amanda Stebbins, et al.
JAMA Cardiology
|
July 13, 2017
Efficacy and Safety of Spironolactone in Acute Heart Failure: The ATHENA-HF Randomized Clinical Trial
Javed Butler, Kevin J Anstrom, G Michael Felker, et al.
Journal of the American College of Cardiology
|
November 24, 2018
Economic and Quality-of-Life Outcomes of Natriuretic Peptide-Guided Therapy for Heart Failure
Daniel B Mark, Patricia A Cowper, Kevin J Anstrom, et al.
Journal of the American College of Cardiology
|
August 31, 2019
Natriuretic Peptide Response and Outcomes in Chronic Heart Failure With Reduced Ejection Fraction
James L Januzzi, Tariq Ahmad, Hillary Mulder, et al.
Circulation. Heart Failure
|
June 18, 2013
Do countries or hospitals with longer hospital stays for acute heart failure have lower readmission rates?: Findings from ASCEND-HF
Zubin J Eapen, Shelby D Reed, Yanhong Li, et al.
JAMA
|
April 9, 2009
Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial
Christopher M O'Connor, David J Whellan, Kerry L Lee, et al.
JAMA
|
November 7, 2018
Effect of Inorganic Nitrite vs Placebo on Exercise Capacity Among Patients With Heart Failure With Preserved Ejection Fraction: The INDIE-HFpEF Randomized Clinical Trial
Barry A Borlaug, Kevin J Anstrom, Gregory D Lewis, et al.
JACC. Heart Failure
|
December 1, 2022
Functional and Symptomatic Clinical Trial Endpoints: The HFC-ARC Scientific Expert Panel
Mitchell A Psotka, William T Abraham, Mona Fiuzat, et al.
Journal of the American College of Cardiology
|
November 12, 2013
Vorapaxar in acute coronary syndrome patients undergoing coronary artery bypass graft surgery: subgroup analysis from the TRACER trial (Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome)
David J Whellan, Pierluigi Tricoci, Edmond Chen, et al.
Journal of the American College of Cardiology
|
November 13, 2020
Conduct of Clinical Trials in the Era of COVID-19: JACC Scientific Expert Panel
Mitchell A Psotka, William T Abraham, Mona Fiuzat, et al.
Page
of 19
Search research articles
Search
Showing results (171-180 of 185) with videos related to
Sort By:
Page
of 19
Journal of Cardiac Failure
|
December 22, 2015
Response to Exercise Training and Outcomes in Patients With Heart Failure and Diabetes Mellitus: Insights From the HF-ACTION Trial
Adam Z Banks, Robert J Mentz, Amanda Stebbins, et al.
JAMA Cardiology
|
July 13, 2017
Efficacy and Safety of Spironolactone in Acute Heart Failure: The ATHENA-HF Randomized Clinical Trial
Javed Butler, Kevin J Anstrom, G Michael Felker, et al.
Journal of the American College of Cardiology
|
November 24, 2018
Economic and Quality-of-Life Outcomes of Natriuretic Peptide-Guided Therapy for Heart Failure
Daniel B Mark, Patricia A Cowper, Kevin J Anstrom, et al.
Journal of the American College of Cardiology
|
August 31, 2019
Natriuretic Peptide Response and Outcomes in Chronic Heart Failure With Reduced Ejection Fraction
James L Januzzi, Tariq Ahmad, Hillary Mulder, et al.
Circulation. Heart Failure
|
June 18, 2013
Do countries or hospitals with longer hospital stays for acute heart failure have lower readmission rates?: Findings from ASCEND-HF
Zubin J Eapen, Shelby D Reed, Yanhong Li, et al.
JAMA
|
April 9, 2009
Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial
Christopher M O'Connor, David J Whellan, Kerry L Lee, et al.
JAMA
|
November 7, 2018
Effect of Inorganic Nitrite vs Placebo on Exercise Capacity Among Patients With Heart Failure With Preserved Ejection Fraction: The INDIE-HFpEF Randomized Clinical Trial
Barry A Borlaug, Kevin J Anstrom, Gregory D Lewis, et al.
JACC. Heart Failure
|
December 1, 2022
Functional and Symptomatic Clinical Trial Endpoints: The HFC-ARC Scientific Expert Panel
Mitchell A Psotka, William T Abraham, Mona Fiuzat, et al.
Journal of the American College of Cardiology
|
November 12, 2013
Vorapaxar in acute coronary syndrome patients undergoing coronary artery bypass graft surgery: subgroup analysis from the TRACER trial (Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome)
David J Whellan, Pierluigi Tricoci, Edmond Chen, et al.
Journal of the American College of Cardiology
|
November 13, 2020
Conduct of Clinical Trials in the Era of COVID-19: JACC Scientific Expert Panel
Mitchell A Psotka, William T Abraham, Mona Fiuzat, et al.
Page
of 19